These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29473245)

  • 41. [Distribution of naloxone to prevent death from heroin overdose. Study of opioid dependent patients' attitudes to be part of the antidote program].
    Håkansson A; Vedin A; Wallin C; Kral AH
    Lakartidningen; 2013 Jul 17-Aug 6; 110(29-31):1340-2. PubMed ID: 23980443
    [No Abstract]   [Full Text] [Related]  

  • 42. Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study.
    Goldman-Hasbun J; DeBeck K; Buxton JA; Nosova E; Wood E; Kerr T
    Harm Reduct J; 2017 Dec; 14(1):79. PubMed ID: 29273031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing causality in drug policy analyses: How useful are the Bradford Hill criteria in analysing take-home naloxone programs?
    Olsen A; McDonald D; Lenton S; Dietze PM
    Drug Alcohol Rev; 2018 May; 37(4):499-501. PubMed ID: 28421696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia.
    Stam NC; Gerostamoulos D; Smith K; Pilgrim JL; Drummer OH
    Clin Toxicol (Phila); 2019 May; 57(5):325-330. PubMed ID: 30451007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.
    Kim HK; Connors NJ; Mazer-Amirshahi ME
    Expert Opin Drug Saf; 2019 Jun; 18(6):465-475. PubMed ID: 31033357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
    Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
    Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Initial Evaluation of Web-Based Opioid Overdose Education.
    Roe SS; Banta-Green CJ
    Subst Use Misuse; 2016 Jan; 51(2):268-75. PubMed ID: 26709867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Initial evaluation of law enforcement overdose training in Rhode Island.
    Saucier CD; Zaller N; Macmadu A; Green TC
    Drug Alcohol Depend; 2016 May; 162():211-8. PubMed ID: 27020323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opioid overdose prevention training with naloxone, an adjunct to basic life support training for first-year medical students.
    Berland N; Fox A; Tofighi B; Hanley K
    Subst Abus; 2017; 38(2):123-128. PubMed ID: 28027016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose Witnesses.
    McDonald R; Breidahl S; Abel-Ollo K; Akhtar S; Clausen T; Day E; Kelleher M; McAuley A; Petersen H; Sefranek M; Thiesen H; Strang J
    Eur Addict Res; 2022; 28(3):220-225. PubMed ID: 35114666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
    O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
    BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.
    Holmén E; Warnqvist A; Kåberg M
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):24. PubMed ID: 37087485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brief overdose education is sufficient for naloxone distribution to opioid users.
    Behar E; Santos GM; Wheeler E; Rowe C; Coffin PO
    Drug Alcohol Depend; 2015 Mar; 148():209-12. PubMed ID: 25595053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid widespread distribution of intranasal naloxone for overdose prevention.
    Madah-Amiri D; Clausen T; Lobmaier P
    Drug Alcohol Depend; 2017 Apr; 173():17-23. PubMed ID: 28182982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
    Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
    Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
    Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
    Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: effective, but dissemination is challenging.
    Mayet S; Manning V; Williams A; Loaring J; Strang J
    Int J Drug Policy; 2011 Jan; 22(1):9-15. PubMed ID: 21044832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lessons learned from ramping up a Canadian Take Home Naloxone programme during a public health emergency: a mixed-methods study.
    Young S; Williams S; Otterstatter M; Lee J; Buxton J
    BMJ Open; 2019 Oct; 9(10):e030046. PubMed ID: 31662368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the Overdose Education and Naloxone Distribution Program of the Baltimore Student Harm Reduction Coalition.
    Lewis DA; Park JN; Vail L; Sine M; Welsh C; Sherman SG
    Am J Public Health; 2016 Jul; 106(7):1243-6. PubMed ID: 27077351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.